Literature DB >> 3753448

Proteoglycans from pig aorta. Comparative study of their interactions with lipoproteins.

J Wegrowski, M Moczar, L Robert.   

Abstract

Different proteoglycans (PGs) were isolated from pig aorta for aggregation studies with hyaluronic acid and human low-density lipoproteins (LDL). Extraction of the intima-media with 4M-guanidinium chloride and digestion of the residue with collagenase solubilized 91% of aortic hexuronic acid content. From the guanidinium chloride extract two PGs were isolated by ion-exchange and gel-permeation chromatography: proteochondroitin sulphate (PGI) with a protein-core apparent Mr of 250 000 and proteodermatan-chondroitin sulphate (PGII) with a protein-core apparent Mr of 55 000. Only PGI forms high-Mr aggregates with hyaluronic acid. From the collagenase digest two other PGs were isolated: proteoheparan sulphate and proteochondroitin sulphate (PGIII and PGIV respectively). PGIV had a smaller hydrodynamic size than PGI. PGI and PGII formed insoluble complexes with human LDL in the presence of Ca2+. PGIII or PGIV did not form precipitates with the LDL. PGI and PGII, but neither PGIII nor PGIV, were bound to LDL-Sepharose. The main peaks of PGI and PGII were eluted from LDL-Sepharose with 60 mM- and 90 mM-NaCl respectively. The results indicate that aortic PGs have different interacting potentials with lipoproteins, depending on their Mr and their glycosaminoglycan composition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753448      PMCID: PMC1146761          DOI: 10.1042/bj2350823

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

Review 1.  Animal models of atherosclerosis, their contributions and pitfalls.

Authors:  D Vesselinovitch
Journal:  Artery       Date:  1979-03

2.  Characterization of bovine aorta proteoglycan extracted with guanidine hydrochloride in the presence of protease inhibitors.

Authors:  T R Oegema; V C Hascall; R Eisenstein
Journal:  J Biol Chem       Date:  1979-02-25       Impact factor: 5.157

3.  Proteinase activity in chondroitin lyase (chondroitinase) and endo-beta-D-galactosidase (keratanase) preparations and a method to abolish their proteolytic effect on proteoglycan.

Authors:  Y Oike; K Kimata; T Shinomura; S Suzuki
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

4.  High molecular weight proteoglycans biosynthesized in culture by pigeon aortas.

Authors:  W D Wagner; J R Connor; E Muldoon
Journal:  Biochim Biophys Acta       Date:  1982-07-16

5.  Interaction of serum lipoproteins and a proteoglycan from bovine aorta.

Authors:  P Vijayagopal; S R Srinivasan; B Radhakrishnamurthy; G S Berenson
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

6.  Isolation and preliminary characterization of proteoglycans dissociatively extracted from human aorta.

Authors:  B G Salisbury; W D Wagner
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

7.  Bovine aortic chondroitin sulphate- and dermatan sulphate-containing proteoglycans. Isolation, fractionation and chemical characterization.

Authors:  R Kapoor; C F Phelps; L Cöster; L A Fransson
Journal:  Biochem J       Date:  1981-08-01       Impact factor: 3.857

8.  Changes in the physical behavior of low density lipoprotein in the presence of glycosaminoglycans and high density lipoprotein.

Authors:  M Bihari-Varga; J Sztatisz; S Gál
Journal:  Atherosclerosis       Date:  1981-04       Impact factor: 5.162

9.  Molecular weight estimation of sulfated glycosaminoglycans in human gingivae.

Authors:  P M Bartold; O W Wiebkin; J C Thonard
Journal:  Connect Tissue Res       Date:  1982       Impact factor: 3.417

10.  Partial characterization of newly synthesized proteoglycans isolated from the glomerular basement membrane.

Authors:  Y S Kanwar; V C Hascall; M G Farquhar
Journal:  J Cell Biol       Date:  1981-08       Impact factor: 10.539

View more
  1 in total

1.  Proteoglycan form of macrophage colony-stimulating factor binds low density lipoprotein.

Authors:  S Suzu; T Inaba; N Yanai; T Kawashima; N Yamada; T Oka; R Machinami; T Ohtsuki; F Kimura; S Kondo
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.